Gene editing firm Graphite Bio prices upsized IPO at $17

Graphite Bio (GRPH) has priced its upsized IPO of 14M common shares at $17.00/share, for expected gross proceeds of $238M.The company initially filed to offer 12.5M shares at a price…
Read More